Medication discontinuation in patients after discharge from a psychiatric hospital

Annals of Pharmacotherapy

Volumn 49, Issue 10, 2015, Pages 1085-1095

  Abdullah Koolmees, Heshu ^a,b,c   Gardarsdottir, Helga ^a,d   Yazir, Dilek ^a   Stoker, Lennart J ^b   Vuyk, Judith ^e   Egberts, Toine C G ^a,d   Heerdink, Eibert R ^a,d,e  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Brocacef Ziekenhuisfarmacie   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e Altrecht Institute for Mental Health Care   (Netherlands)

Author keywords

Change of setting; Changes; Continuation of care; Discharge; Discontinuation; Medication; Psychiatric hospital; Psychiatry

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANXIOLYTIC AGENT; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DERMATOLOGICAL AGENT; LAXATIVE; MOOD STABILIZER; NEUROLEPTIC AGENT; SEDATIVE AGENT; STABILIZING AGENT; VITAMIN;

ADDICTION; ADULT; AMNESIA; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DELIRIUM; DEMENTIA; DEPRESSION; DRUG SAFETY; DRUG USE; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HOSPITAL; MENTAL PATIENT; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCHOSOMATIC DISORDER; RETROSPECTIVE STUDY; RISK FACTOR; SCHIZOPHRENIA; TREATMENT WITHDRAWAL; CHRONIC DISEASE; MEDICATION COMPLIANCE; PATIENT CARE; RISK;

ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; CONTINUITY OF PATIENT CARE; FOLLOW-UP STUDIES; HOSPITALS, PSYCHIATRIC; HUMANS; MEDICATION ADHERENCE; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; RISK;

EID: 84952773988     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028015593763     Document Type: Article

References (47)

1. Abdullah-Koolmees H, Gardarsdottir H, Stoker LJ, Vuyk J, Egberts TC, Heerdink ER. Discontinuation of somatic medication during psychiatric hospitalization. Ann Pharmacother. 2014;48:1415-1425. doi:10. 1177/1060028014544897.
2. Stuffken R, Egberts TC. Discontinuities in drug use upon hospital discharge. Pharm World Sci. 2004;26:268-270.
3. Stuffken R, Heerdink ER, de Koning FH, Souverein PC, Egberts AC. Association between hospitalization and discontinuity of medication therapy used in the community setting in the Netherlands. Ann Pharmacother. 2008;42:933-939. doi:10. 1345/aph. 1L062.
4. Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. CMAJ. 2005;173:510-515. doi:10. 1503/cmaj. 045311.
5. Karapinar F, van den Bemt PM, Zoer J, Nijpels G, Borgsteede SD. Informational needs of general practitioners regarding discharge medication: content, timing and pharmacotherapeutic advice. Pharm World Sci. 2010;32:172-178. doi:10. 1007/ s11096-009-9363-3.
6. Grimmsmann T, Schwabe U, Himmel W. The influence of hospitalisation on drug prescription in primary care-a largescale follow-up study. Eur J Clin Pharmacol. 2007;63: 783-790. doi:10. 1007/s00228-007-0325-1.
7. Corry M, Bonner G, McEntee S, Dugan J, MacAuley D. Hospitals do not inform GPs about medication that should be monitored. Fam Pract. 2000;17:268-271.
8. Himmel W, Kochen MM, Sorns U, Hummers-Pradier E. Drug changes at the interface between primary and secondary care. Int J Clin Pharmacol Ther. 2004;42:103-109.
9. Bolas H, Brookes K, Scott M, McElnay J. Evaluation of a hospital- based community liaison pharmacy service in Northern Ireland. Pharm World Sci. 2004;26:114-120.
10. Zhou Y, Rosenheck RA, Mohamed S, Fan N, Ning Y, He H. Retrospective assessment of factors associated with readmission in a large psychiatric hospital in Guangzhou, China. Shanghai Arch Psychiatry. 2014;26:138-148. doi:10. 3969/ j. issn. 1002-0829. 2014. 03. 005.
11. Tomko JR, Ahmed N, Mukherjee K, Roma RS, Dilucente D, Orchowski K. Evaluation of a discharge medication service on an acute psychiatric unit. Hosp Pharm. 2013;48:314-320. doi:10. 1310/hpj4804-314. test.
12. Vigod SN, Kurdyak PA, Dennis CL, et al. Transitional interventions to reduce early psychiatric readmissions in adults: systematic review. Br J Psychiatry. 2013;202:187-194. doi:10. 1192/bjp. bp. 112. 115030.
13. De Hert M, van Winkel R, Silic A, Van Eyck D, Peuskens J. Physical health management in psychiatric settings. Eur Psychiatry. 2010;25(suppl 2):S22-S28. doi:10. 1016/S0924- 9338(10)71702-8.
14. Abdullah-Koolmees H, Gardarsdottir H, Stoker LJ, Vuyk J, Egberts TC, Heerdink ER. Prevalence of medication use for somatic disease in institutionalized psychiatric patients. Pharmacopsychiatry. 2013;46:274-280. doi:10. 1055/s-0033-1354405.
15. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27: 596-601.
16. De Hert M, Vancampfort D, Correll CU, et al. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry. 2011;199: 99-105. doi:10. 1192/bjp. bp. 110. 084665.
17. Iacovides A, Siamouli M. Comorbid mental and somatic disorders: an epidemiological perspective. Curr Opin Psychiatry. 2008;21:417-421. doi:10. 1097/YCO. 0b013e328303ba42.
18. Dixon L, Postrado L, Delahanty J, Fischer PJ, Lehman A. The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis. 1999;187: 496-502.
19. Miller BJ, Paschall CB 3rd, Svendsen DP. Mortality and medical comorbidity among patients with serious mental illness. Psychiatr Serv. 2006;57:1482-1487. doi:10. 1176/appi. ps. 57. 10. 1482.
20. Mookhoek EJ, Van De Kerkhof PC, Hovens JE, Brouwers JR, Loonen AJ. Skin disorders in chronic psychiatric illness. J Eur Acad Dermatol Venereol. 2010;24:1151-1156. doi:10. 1111/j. 1468-3083. 2010. 03609. x.
21. Katsamanis M, Lehrer PM, Escobar JI, Gara MA, Kotay A, Liu R. Psychophysiologic treatment for patients with medically unexplained symptoms: a randomized controlled trial. Psychosomatics. 2011;52:218-229. doi:10. 1016/j. psym. 2011. 01. 015.
22. Simon GE, VonKorff M. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area study. Am J Psychiatry. 1991;148:1494-1500.
23. Walker EA, Roy-Byrne PP, Katon WJ. Irritable bowel syndrome and psychiatric illness. Am J Psychiatry. 1990;147: 565-572.
24. Walker EA, Roy-Byrne PP, Katon WJ, Li L, Amos D, Jiranek G. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry. 1990;147:1656-1661.
25. Andreski P, Chilcoat H, Breslau N. Post-traumatic stress disorder and somatization symptoms: a prospective study. Psychiatry Res. 1998;79:131-138.
26. Engel CC Jr, Liu X, McCarthy BD, Miller RF, Ursano R. Relationship of physical symptoms to posttraumatic stress disorder among veterans seeking care for Gulf War-related health concerns. Psychosom Med. 2000;62:739-745.
27. Deary IJ. A taxonomy of medically unexplained symptoms. J Psychosom Res. 1999;47:51-59.
28. Maayan L, Correll CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2011;21:517-535. doi:10. 1089/cap. 2011. 0015.
29. Stoklosa J, Ongur D. Rational antipsychotic choice: weighing the risk of tardive dyskinesia and metabolic syndrome. Harv Rev Psychiatry. 2011;19:271-276. doi:10. 3109/10673229. 20 11. 614100.
30. Hill KD, Wee R. Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem. Drugs Aging. 2012;29:15-30. doi:10. 2165/11598420- 000000000-00000.
31. Sylvestre MP, Abrahamowicz M, Capek R, Tamblyn R. Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly. Int Psychogeriatr. 2012;24:577-586. doi:10. 1017/S1041610211002031.
32. Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C. Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis. J Clin Psychopharmacol. 2012;32:309-316. doi:10. 1097/JCP. 0b013e3182549259.
33. Jonsdottir H, Friis S, Horne R, Pettersen KI, Reikvam A, Andreassen OA. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand. 2009;119:78-84. doi:10. 1111/ j. 1600-0447. 2008. 01279. x.
34. Abdullah-Koolmees H, Gerbranda T, Deneer VH, et al. Discontinuation of anticoagulant care during admission to a psychiatric hospital. Eur J Clin Pharmacol. 2012;69: 1025-1029. doi:10. 1007/s00228-012-1398-z.
35. Laan W, Does Y, Sezgi B, et al. Low treatment adherence with antipsychotics is associated with relapse in psychotic disorders within six months after discharge. Pharmacopsychiatry. 2010;43:221-224. doi:10. 1055/s-0030-1254090.
36. Altrecht MHC, 2013. Annual Report 2013 of Altrecht/ Jaarverslag; 2013:19-94.
37. World Health Organization. WHO/DDD Index 2015. http:// www. whocc. no/atc_ddd_index/. Accessed April 19, 2015.
38. Smeets HM, Laan W, Engelhard IM, Boks MP, Geerlings MI, de Wit NJ. The psychiatric case register middle Netherlands. BMC Psychiatry. 2011;11:106. doi:10. 1186/1471-244X-11-106.
39. Karapinar-Çarkit F, van Breukelen BR, Borgsteede SD, Janssen MJ, Egberts AC, van den Bemt PM. Completeness of patient records in community pharmacies post-discharge after in-patient medication reconciliation: a before-after study. Int J Clin Pharm. 2014;36:807-814. doi:10. 1007/s11096-014- 9965-2.
40. Prins MC, Drenth-van Maanen AC, Kok RM, Jansen PA. Use of a structured medication history to establish medication use at admission to an old age psychiatric clinic: a prospective observational study. CNS Drugs. 2013;27:963-969. doi:10. 1007/s40263-013-0103-9.
41. Mann E, Haastert B, Bohmdorfer B, et al. Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study. Wien Klin Wochenschr. 2013;125: 180-188. doi:10. 1007/s00508-013-0342-2.
42. Policy Document: transfer of information on medication [in Dutch]. 2012. http://www. medicatieoverdracht. nl/. Accessed July 17, 2014.
43. Holland DM. Interdisciplinary collaboration in the provision of a pharmacist-led discharge medication reconciliation service at an Irish teaching hospital. Int J Clin Pharm. 2015;37:310-319. doi:10. 1007/s11096-014-0059-y.
44. Tedesco GW, McConaha JL, Skomo ML, Higginbotham SK. A pharmacist's impact on 30-day readmission rates when compared to the current standard of care within a patient-centered medical home: a pilot study [published online January 8, 2015]. J Pharm Pract. doi:10. 1177/0897190014568671.
45. Stuhec M, Alisky J, Malesic I. Mirtazapine associated with drug-related thrombocytopenia: a case report. J Clin Psychopharmacol. 2014;34:662-664. doi:10. 1097/ JCP. 0000000000000201.
46. Stuhec M. Trimethoprim-sulfamethoxazole-related hallucinations. Gen Hosp Psychiatry. 2014;36:230. e7-230. e8. doi:10. 1016/j. genhosppsych. 2013. 10. 016.
47. Mitchell AJ, Lord O, Malone D. Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis. Br J Psychiatry. 2012;201:435-443. doi:10. 1192/bjp. bp. 111. 094532.